A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma
Public ClinicalTrials.gov record NCT03606174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibitor regimens in combination with the investigational agent sitravatinib in patients with advanced or metastatic urothelial carcinoma.
Study identification
- NCT ID
- NCT03606174
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 260 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 11, 2018 (Actual)
- Primary completion
- Aug 3, 2022 (Actual)
- Completion
- Aug 22, 2022 (Actual)
- Last update posted
- Aug 24, 2023
2018 – 2022
United States locations
- U.S. sites
- 36
- U.S. states
- 23
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| University of California Irvine | Irvine | California | 92868 | — |
| Rocky Mountain Cancer Centers | Aurora | Colorado | 80012 | — |
| Yale School of Medicine | New Haven | Connecticut | 06510 | — |
| SCRI - Florida Cancer Specialists- North Region | St. Petersburg | Florida | 33705 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| SCRI - Florida Cancer Specialists - West Palm Beach | West Palm Beach | Florida | 33401 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Indiana University - Melvin & Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| Norton Cancer Institute - Broadway | Louisville | Kentucky | 40202 | — |
| Ochsner Cancer Institute | New Orleans | Louisiana | 70121 | — |
| Maryland Oncology Hematology, P.A. | Lanham | Maryland | 20706 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Washington University School of Medicine - Siteman Cancer Center | St Louis | Missouri | 63110 | — |
| GU Research Network/Urology Cancer Center | Omaha | Nebraska | 68130 | — |
| Comprehensive Cancer Centers of Nevada - Southwest | Las Vegas | Nevada | 89169 | — |
| New York Oncology Hematology - Albany Medical Center | Albany | New York | 12206 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Northwell Health Monter Cancer Center | Lake Success | New York | 11042 | — |
| NYU Langone Laura & Isaac Perlmutter Cancer Center | New York | New York | 10016 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| New York-Presbyterian - Weill Cornell Medical Center | New York | New York | 10065 | — |
| University of North Carolina - Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | — |
| Duke University Hospital | Durham | North Carolina | 27710 | — |
| The Ohio State University College of Medicine | Columbus | Ohio | 43202 | — |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | — |
| Vanderbilt University - Ingram Cancer Center | Nashville | Tennessee | 37232 | — |
| Texas Oncology-Austin Central | Austin | Texas | 78731 | — |
| Texas Oncology- Memorial City | Houston | Texas | 77024 | — |
| University of Texas - MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| University of Texas Health Science Center | San Antonio | Texas | 78229 | — |
| Texas Oncology - Tyler | Tyler | Texas | 75702 | — |
| Virginia Cancer Specialists- Fairfax | Fairfax | Virginia | 22031 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Seattle Cancer Center Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03606174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03606174 live on ClinicalTrials.gov.